One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near? - Schmitt, Christina; Grundt, Alexander; Buchholtz, Christian; Scheuer, Lars; Benner, Axel; Hensel, Manfred; Ho, Anthony Dick; Leo, Eugen (Leukemia research, 2006)
Available online: 10 March 2006